A
Ana Pardo Sanz
Publications - 26
Citations - 190
Ana Pardo Sanz is an academic researcher. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 6, co-authored 17 publications receiving 111 citations.
Papers
More filters
Journal ArticleDOI
Frailty predicts major bleeding within 30 days in elderly patients with Acute Coronary Syndrome
Gonzalo Luis Alonso Salinas,Marcelo Sanmartín Fernández,Marina Pascual Izco,Álvaro Marco del Castillo,Luis Miguel Rincón Díaz,Cristina Lozano Granero,María Valverde Gómez,Pablo Pastor Pueyo,David del Val Martín,Ana Pardo Sanz,Juan Manuel Monteagudo Ruiz,Alejandro Recio-Mayoral,Luis Salvador Ramos,Domingo Marzal Martín,Asunción Camino López,Manuel Jiménez Mena,José Luis Zamorano Gómez +16 more
TL;DR: Frailty phenotype, as a marker of biological vulnerability, is an independent predictor of major bleeding in elderly patients with ACS, and objective indices should be integrated into routine initial evaluation of these patients.
Journal ArticleDOI
New-onset atrial fibrillation during COVID-19 infection predicts poor prognosis.
Ana Pardo Sanz,Luisa Salido Tahoces,Rodrigo Ortega Pérez,Eduardo González Ferrer,Ángel Sánchez Recalde,José Luis Zamorano Gómez +5 more
TL;DR: The appearance of new-onset AF in COVID-19 patients presumably has a notable impact on prognosis, and is related to worse cardiovascular outcomes, considering it as an independent predictor of embolic events.
Journal ArticleDOI
Factores de riesgo de muerte hospitalaria en pacientes con infarto agudo de miocardio durante la pandemia de la COVID-19
Jorge Solano-López,José Luis Zamorano,Ana Pardo Sanz,Ignacio J. Amat-Santos,Fernando Sarnago,Enrique Gutiérrez Ibañes,Juan Sanchis,Juan Ramón Rey Blas,Joan Antoni Gómez-Hospital,Sandra Santos Martínez,Nicolás Manuel Maneiro-Melón,Roberto Mateos Gaitán,Jessika González D’Gregorio,Luisa Salido,José Luis Mestre,Marcelo Sanmartín,Ángel Sánchez-Recalde +16 more
TL;DR: In this article, an estudio of cohortes, prospectivo and multicentrico of todos the pacients consecutivos with IAM in tratamiento invasivo durante el brote de COVID-19 (15 de marzo a 15 de abril de 2020).
Journal ArticleDOI
AF in Cancer Patients: A Different Need for Anticoagulation?
TL;DR: Cardiology involvement in the management of these patients seems to be associated with favourable AF-related outcomes, and little is known about whether embolic and bleeding risk scores used for the general population can be applied in oncologic patients.
Journal ArticleDOI
Current status of anticoagulation in patients with breast cancer and atrial fibrillation.
Ana Pardo Sanz,L M Rincon,Paula Guedes Ramallo,Laia Carla Belarte Tornero,Gregorio de Lara Delgado,Alejandra Tamayo Obregon,Alejandro Cruz-Utrilla,Helena Contreras Mármol,Andrea Martínez-Cámara,Sergio Huertas Nieto,Juan José Portero-Portaz,Luisa Salido Tahoces,José Luis Zamorano Gómez +12 more
TL;DR: Antithrombotic management of AF frequently differs in patients with breast cancer, and patients with cancer treated with DOACs and VKAs experienced similar rates of stroke and bleeding as those with VKAs.